脑微出血的临床意义及其伴心房颤动时的抗凝治疗决策进展

摘要/Abstract

中图分类号:

R743

武冬冬, 胡夏生, 刘银红, 蒋景文. 脑微出血的临床意义及其伴心房颤动时的抗凝治疗决策进展[J]. 诊断学理论与实践, 2020, 19(05): 534-539.

图/表3

分类	机制
原发性CMB	动脉和（或）小动脉破裂, 血脑屏障破坏和（或）毛细血管中断
继发性CMB	出血性梗死, 出血性微梗死
假性CMB	缺血诱导的少突胶质细胞内贮存铁的释放, 血管自噬^a)

参考文献49

[1]	Offenbacher H, Fazekas F, Schmidt R, et al. MR of cerebral abnormalities concomitant with primary intracerebral hematomas[J]. Am J Neuroradiol, 1996, 17(3):573-578. pmid:8881257
[2]	Fazekas F, Kleinert R, Roob G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intra-cerebral hemorrhage: evidence of microangiopathy-related microbleeds[J]. Am J Neuroradiol, 1999, 20(4):637-642. pmid:10319975
[3]	Poels MM, Vernooij MW, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study[J]. Stroke, 2010, 41(10 Suppl):S103-S106.
[4]	Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting[J]. Brain, 2007, 130(Pt 8):1988-2003. doi:10.1093/brain/awl387pmid:17322562
[5]	Fisher M. Cerebral microbleeds: where are we now?[J]. Neurology, 2014, 83(15):1304-1305. doi:10.1212/WNL.0000000000000871pmid:25186856
[6]	Cheng AL, Batool S, McCreary CR, et al. Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds[J]. Stroke, 2013, 44(10):2782-2786. doi:10.1161/STROKEAHA.113.002267 URL
[7]	Rockson SG, Albers GW. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation[J]. J Am Coll Cardiol, 2004, 43(6):929-935. doi:10.1016/j.jacc.2003.11.028 URL
[8]	Saito T, Kawamura Y, Tanabe Y, et al. Cerebral microbleeds and asymptomatic cerebral infarctions in patients with atrial fibrillation[J]. J Stroke Cerebrovasc Dis, 2014, 23(6):1616-1622. doi:10.1016/j.jstrokecerebrovasdis.2014.01.005 URL
[9]	European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)[J]. Eur Heart J, 2010, 31(19):2369-2429. doi:10.1093/eurheartj/ehq278 URL
[10]	Dowlatshahi D, Butcher KS, Asdaghi N, et al. Poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal[J]. Stroke, 2012, 43(7):1812-1817. doi:10.1161/STROKEAHA.112.652065pmid:22556194
[11]	Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation[J]. Lancet Neurol, 2009, 8(2):165-174. doi:10.1016/S1474-4422(09)70013-4pmid:19161908
[12]	Lovelock CE, Cordonnier C, Naka H, et al. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies[J]. Stroke, 2010, 41(6):1222-1228. doi:10.1161/STROKEAHA.109.572594 URL
[13]	Jeon SB, Kang DW, Cho AH, et al. Initial microbleeds at MR imaging can predict recurrent intracerebral hemorrhage[J]. J Neurol, 2007, 254(4):508-512. doi:10.1007/s00415-006-0406-6 URL
[14]	Imaizumi T, Inamura S, Nomura T. Contribution of deep microbleeds to stroke recurrence: differences between patients with past deep intracerebral hemorrhages and lacunar infarctions[J]. J Stroke Cerebrovasc Dis, 2015, 24(8):1855-1864. doi:10.1016/j.jstrokecerebrovasdis.2015.04.027pmid:25980343
[15]	Vermeer SE, Algra A, Franke CL, et al. Long-term prognosis after recovery from primary intracerebral hemorrhage[J]. Neurology, 2002, 59(2):205-209. pmid:12136058
[16]	Charidimou A, Kakar P, Fox Z, et al. Cerebral micro-bleeds and recurrent stroke risk: systematic review and meta-analysis of prospective ischemic stroke and transient ischemic attack cohorts[J]. Stroke, 2013, 44(4):995-1001. doi:10.1161/STROKEAHA.111.000038pmid:23493732
[17]	Wilson D, Charidimou A, Ambler G, et al. Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA: a meta-analysis[J]. Neurology, 2016, 87(14):1501-1510. doi:10.1212/WNL.0000000000003183 URL
[18]	Akoudad S, Portegies ML, Koudstaal PJ, et al. Cerebral microbleeds are associated with an increased risk of stroke: the rotterdam study[J]. Circulation, 2015, 132(6):509-516. doi:10.1161/CIRCULATIONAHA.115.016261pmid:26137955
[19]	Charidimou A, Karayiannis C, Song TJ, et al. Brain microbleeds, anticoagulation, and hemorrhage risk: meta-analysis in stroke patients with AF[J]. Neurology, 2017, 89(23):2317-2326. doi:10.1212/WNL.0000000000004704pmid:29117953
[20]	Song TJ, Kim J, Song D, et al. Association of cerebral microbleeds with mortality in stroke patients having atrial fibrillation[J]. Neurology, 2014, 83(15):1308-1315. doi:10.1212/WNL.0000000000000862 URL
[21]	Eckman MH, Wong LK, Soo YO, et al. Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help?[J]. Stroke, 2008, 39(12):3308-3315. doi:10.1161/STROKEAHA.108.523159pmid:18845797
[22]	Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatranversuswarfarin in patients with atrial fibrillation[J]. N Engl J Med, 2009, 361(12):1139-1151. doi:10.1056/NEJMoa0905561 URL
[23]	Granger CB, Alexander JH, McMurray JJ, et al. Apixabanversuswarfarin in patients with atrial fibrillation[J]. N Engl J Med, 2011, 365(11):981-992. doi:10.1056/NEJMoa1107039 URL
[24]	Patel MR, Mahaffey KW, Garg J, et al. Rivaroxabanversuswarfarin in nonvalvular atrial fibrillation[J]. N Engl J Med, 2011, 365(10):883-891. doi:10.1056/NEJMoa1009638 URL
[25]	Cervera A, Amaro S, Chamorro A. Oral anticoagulant-associated intracerebral hemorrhage[J]. J Neurol, 2012, 259(2):212-224. doi:10.1007/s00415-011-6153-3pmid:21748282
[26]	Eckman MH, Rosand J, Knudsen KA, et al. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis[J]. Stroke, 2003, 34(7):1710-1716. pmid:12805495
[27]	Greenberg SM, Eng JA, Ning M, et al. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage[J]. Stroke, 2004, 35(6):1415-1420. pmid:15073385
[28]	Kuramatsu JB, Gerner ST, Schellinger PD, et al. Anticoa-gulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intra-cerebral hemorrhage[J]. JAMA, 2015, 313(8):824-836. doi:10.1001/jama.2015.0846pmid:25710659
[29]	Passero S, Burgalassi L, D'Andrea P, et al. Recurrence of bleeding in patients with primary intracerebral hemorrhage[J]. Stroke, 1995, 26(7):1189-1192. pmid:7604411
[30]	Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2015, 46(7):2032-2060. doi:10.1161/STR.0000000000000069pmid:26022637
[31]	Wilson D, Jäger HR, Werring DJ. Anticoagulation for atrial fibrillation in patients with cerebral microbleeds[J]. Curr Atheroscler Rep, 2015, 17(8):47. doi:10.1007/s11883-015-0524-7 URL
[32]	Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review[J]. Neurology, 2007, 69(6):546-554. doi:10.1212/01.wnl.0000267275.68538.8d URL
[33]	Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas[J]. Stroke, 2005, 36(7):1588-1593. doi:10.1161/01.STR.0000170642.39876.f2 URL
[34]	Song TJ, Kim J, Lee HS, et al. The frequency of cerebral microbleeds increases with CHADS(2) scores in stroke patients with non-valvular atrial fibrillation[J]. Eur J Neurol, 2013, 20(3):502-508. doi:10.1111/ene.12003pmid:23057579
[35]	Wilson D, Ambler G, Shakeshaft C, et al. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study[J]. Lancet Neurol, 2018, 17(6):539-547. doi:10.1016/S1474-4422(18)30145-5 URL
[36]	Soo Y, Abrigo JM, Leung KT, et al. Risk of intracerebral whaemorrhage in Chinese patients with atrial fibrillation on warfarin with cerebral microbleeds: the IPAAC-warfarin study[J]. J Neurol Neurosurg Psychiatry, 2019, 90(4):428-435. doi:10.1136/jnnp-2018-319104 URL
[37]	Wilson D, Charidimou A, Ambler G, et al. Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA: a meta-analysis[J]. Neurology, 2016, 87(14):1501-1510. doi:10.1212/WNL.0000000000003183 URL
[38]	Selim M, Diener HC. Atrial fibrillation and microbleeds[J]. Stroke, 2017, 48(10):2660-2664. doi:10.1161/STROKEAHA.117.017085 URL
[39]	Lip GY, Andreotti F, Fauchier L, et al. Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis[J]. Europace, 2011, 13(5):723-746. doi:10.1093/europace/eur126 URL
[40]	Hylek EM, Evans-Molina C, Shea C, et al. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation[J]. Circulation, 2007, 115(21):2689-2696. doi:10.1161/CIRCULATIONAHA.106.653048 URL
[41]	Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey[J]. Chest, 2010, 138(5):1093-1100. doi:10.1378/chest.10-0134pmid:20299623
[42]	Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials[J]. Lancet, 2014, 383(9921):955-962. doi:10.1016/S0140-6736(13)62343-0 URL
[43]	Lee SH, Ryu WS, Roh JK. Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage[J]. Neurology, 2009, 72(2):171-176. doi:10.1212/01.wnl.0000339060.11702.dd URL
[44]	Saito T, Kawamura Y, Sato N, et al. Non-vitamin K anta-gonist oral anticoagulants do not increase cerebral micro-bleeds[J]. J Stroke Cerebrovasc Dis, 2015, 24(6):1373-1377. doi:10.1016/j.jstrokecerebrovasdis.2015.02.018 URL
[45]	Fisher M. MRI screening for chronic anticoagulation in atrial fibrillation[J]. Front Neurol, 2013, 4:137. doi:10.3389/fneur.2013.00137pmid:24109470
[46]	Wang Z, Soo YO, Mok VC. Cerebral microbleeds: is antithrombotic therapy safe to administer?[J]. Stroke, 2014, 45(9):2811-2817. doi:10.1161/STROKEAHA.114.004286 URL
[47]	Smith EE, Saposnik G, Biessels GJ, et al. Prevention of stroke in patients with silent cerebrovascular disease: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2017, 48:e44-e71.
[48]	Microbleeds International Collaborative Network. Worldwide collaboration in the Microbleeds International Collaborative Network[J]. Lancet Neurol, 2016, 15(11):1113-1114. doi:10.1016/S1474-4422(16)30213-7 URL
[49]	Charidimou A, Soo Y, Heo JH, et al. A call for researchers to join the META-MICROBLEEDS Consortium[J]. Lancet Neurol, 2016, 15(9):900. doi:S1474-4422(16)30124-7pmid:27478945

脑微出血的临床意义及其伴心房颤动时的抗凝治疗决策进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表3

参考文献49

相关文章15

编辑推荐

Metrics

本文评价

[1]	罗晓颖, 许燕, 张凤如, 吴立群, 戚文航.P波离散度和N端脑钠肽前体预测房颤冷冻球囊导管消融术后复发的价值[J]. 诊断学理论与实践, 2020, 19(1): 32-36.
[2]	刘彤, 王鑫.心房颤动预后不良风险的评估策略[J]. 诊断学理论与实践, 2020, 19(06): 555-558.
[3]	罗晓颖, 许燕, 张建盛, 吴立群, 戚文航.N端脑钠肽前体预测首次急性心肌梗死后新发心房颤动的价值研究[J]. 诊断学理论与实践, 2020, 19(03): 303-307.
[4]	王晨琛, 杨文波, 华玮, 陈晔芬, 苏秀秀, 龚俊世, 方跃华.左心耳解剖形态、功能与非瓣膜性心房颤动患者脑卒中发生风险的相关性研究[J]. 诊断学理论与实践, 2020, 19(02): 151-156.
[5]	毛毅敏, 黄伸伸, 和雪改.围手术期静脉血栓栓塞症形成风险评估及抗凝药物管理[J]. 诊断学理论与实践, 2019, 18(1): 16-20.
[6]	胡荣郭, 庞德芳, 黄澍, 沈振坤, 陈玮, 杨育伟, 来小音, 朱玮, 吴菲菲, 计海峰, 吴大玉, 江梅, 孙家兰, 李龙宣.急性缺血性卒中早期血浆miRNAs水平与房颤发生间的关系[J]. 诊断学理论与实践, 2017, 16(01): 98-103.
[7]	黄红漫, 查爽英, 刘新兵, 柏晓松, 冯六六.超高龄心房颤动患者华法林抗凝过程中心血管不良事件的观察[J]. 诊断学理论与实践, 2016, 15(05): 513-516.
[8]	刘兴鹏, 廖文凯,.心房颤动的驱动机制认识[J]. 诊断学理论与实践, 2015, 14(03): 197-200.
[9]	吴立群,.心房颤动的现代诊断及导管消融治疗进展认识[J]. 诊断学理论与实践, 2015, 14(03): 201-203.
[10]	陈松文, 刘少稳,.心房颤动患者应用新型口服抗凝药物的指南解读[J]. 诊断学理论与实践, 2015, 14(03): 204-207.
[11]	吴杰,.自主神经异常与心房颤动[J]. 诊断学理论与实践, 2015, 14(03): 208-210.
[12]	徐亚伟, 唐恺,.左心耳封堵预防房颤卒中的原理及临床价值[J]. 诊断学理论与实践, 2015, 14(03): 211-214.
[13]	罗晓颖, 权薇薇, 许燕, 张风如, 吴立群, 戚文航,.C反应蛋白与房颤冷冻球囊导管消融术后房颤复发的相关性研究[J]. 诊断学理论与实践, 2015, 14(03): 219-222.
[14]	.互刊信息[J]. 诊断学理论与实践, 2008, 7(04): 442-.
[15]	金奇, 吴立群,.心肌连接蛋白在心房颤动发生机制中的作用[J]. 诊断学理论与实践, 2007, 6(03): 266-268.